During the past decade, Sierra Eye Associates conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 19 clinical trials were completed, i.e. on average, 29.2% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 18 clinical trials were completed. i.e. 47.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sierra Eye Associates" #1 sponsor was "Hoffmann-La Roche" with 17 trials, followed by "Genentech, Inc." with 8 trials sponsored, "Kodiak Sciences Inc" with 6 trials sponsored, "Gyroscope Therapeutics Limited" with 5 trials sponsored and "ThromboGenics" with 5 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sierra Eye Associates" #1 collaborator was "Novartis Pharmaceuticals" with 5 trials as a collaborator, "Chugai Pharmaceutical" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Sierra Eye Associates" are "Diabetic Macular Edema" (15 trials), "Geographic Atrophy" (15 trials), "Macular Degeneration" (11 trials), "Diabetic Retinopathy" (7 trials) and "Dry Age-related Macular Degeneration" (5 trials). Many other conditions were trialed in "Sierra Eye Associates" in a lesser frequency.

Most popular intervention types in "Sierra Eye Associates" are "Drug" (55 trials), "Other" (14 trials), "Device" (5 trials), "Procedure" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (14 trials), "Aflibercept" (11 trials), "Faricimab" (9 trials), "KSI-301" (6 trials) and "Ranibizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Sierra Eye Associates" are 67 trials for "All" genders.

Currently, there are NaN active trials in "Sierra Eye Associates". undefined are not yet recruiting, 8 are recruiting, 20 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 28 completed trials in Sierra Eye Associates, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Sierra Eye Associates, 12 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".